Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell–cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There they can potentiate further tumorigenesis via differentiation into tumor-nurturing stroma (TAF, myofibroblasts) [82, 104], direct cell contact interaction with cancer cells [105, 106] or release of paracrine factors (Table 2).”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [106]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The anti-tumorigenic and pro-apoptotic effect of MSCs results from the suppression of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in some cancer types [59].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Existing data from pre-clinical studies regarding the pro-apoptotic effect of MSCs on cancer cells through the downregulation of PI3K/Akt pathway support this antitumor potential in hepatocellular carcinoma, glioma cells, Kaposi's sarcoma, and prostate and breast cancer [61], [62], [63], [64], [65].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · cited 1×
“The myristoylated Akt plasmid (myrAkt) has been previously described (49)”
BackgroundStromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Cited by
Items 501–600 of 747
Adult human sarcomas. I. Basic science
Sinkovics, J. G. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.1.31 · Cited by 13
Mesenchymal Stem Cell Treatment of Inflammation-Induced Cancer
Prakash, M. D., Miller, S., Randall‐Demllo, S., & Nurgali, K. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000900 · Cited by 15
Mesenchymal Stem Cells: “Repair Cells” that Serve Wounds and Cancer?
Dittmer, J. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.119 · Cited by 12
Nikkhah, E., Kalalinia, F., Rezaee, M. A., & Tayarani‐Najaran, Z. (2021) · PubMed Central · doi:10.22038/ijbms.2021.58273.12946 · Cited by 12
Stem cell therapy applied for digestive anastomosis: Current state and future perspectives
Trébol, J., Georgiev-Hristov, T., Pascual, I., Guadalajara, H., García‐Arranz, M., & García‐Olmo, D. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i1.117 · Cited by 12
Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer
Švajger, U., & Kamenšek, U. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.03.002 · Cited by 13
The Use of Mesenchymal Stem Cells for the Treatment of Progressive Retinal Diseases: A Review
Borkowska-Kuczkowska, A., Sługocka, D., Świątkowska-Flis, B., & Boruczkowski, D. (2019) · Regenerative Medicine · doi:10.2217/rme-2019-0022 · Cited by 13
Lee, J., Ung, A., Kim, H., Lee, K., Cho, H., Bandaru, P., Ahadian, S., Dokmeci, M. R., & Khademhosseini, A. (2021) · Biofabrication · doi:10.1088/1758-5090/ac36de · Cited by 12
Zhao, Y., Chen, J., Dai, X., Cai, H., Ji, X., Sheng, Y., Liu, H., Yang, L., Chen, Y., Xi, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22301 · Cited by 13
Zhang, Z., Shao, S., Liu, X., & Tong, Z. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28702 · Cited by 11
Link Between Cancer Stem Cells and Adult Mesenchymal Stromal Cells: Implications for Cancer Therapy
Jørgensen, C. (2009) · Regenerative Medicine · doi:10.2217/17460751.4.2.149 · Cited by 11
Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers
Wang, N., Pei, B., Yuan, X., Yi, C., Ocansey, D. K. W., Qian, H., & Mao, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1019459 · Cited by 16
Fath, M. K., Banan, Z. M., Barati, R., Mohammadrezakhani, O., Ghaderi, A., Hatami, A., Ghiabi, S., Zeidi, N., Asgari, K., Payandeh, Z., et al. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.02.001 · Cited by 11
Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
Johann, P. D., & Müller, I. (2015) · Stem Cells International · doi:10.1155/2015/914632 · Cited by 13
Katsuno, T., Ochi, M., Tominaga, K., Tanaka, F., Sogawa, M., Tanigawa, T., Yamagami, H., Shiba, M., Watanabe, K., Watanabe, T., et al. (2013) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.13-68 · Cited by 12
Inhibitory effect and mechanism of mesenchymal stem cells on melanoma cells
Zhang, J., Hou, L., Zhao, D., Pan, M., Wang, Z., Hu, H., & He, J. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1677-3 · Cited by 11
Self-citationGladkova, N., Umezu, T., Imanishi, S., Kawana, C., Ohyashiki, J. H., & Ohyashiki, K. (2020) · Human Cell · doi:10.1007/s13577-020-00332-y · Cited by 11
Reconstitution of Schwannian Stroma in Neuroblastomas Using Human Bone Marrow Stromal Cells
Du, W., Hozumi, N., Sakamoto, M., Hata, J.-I., & Yamada, T. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070309 · Cited by 11
Saeedi, M., Nezhad, M. S., Mehranfar, F., Golpour, M., Esakandari, M. A., Rashmeie, Z., Ghorbani, M., Nasimi, F., & Hoseinian, S. N. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200907121530 · Cited by 12
Stem Cell Biology in Health and Disease
Dittmar, T., & Zänker, K. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-3040-5 · Cited by 12
Xing, Z., Lin, D., Hong, Y., Ma, Z., Jiang, H., Ye, L., Sun, J., Song, J., Xie, L., Yang, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1186858 · Cited by 10
Taeb, S., Rostamzadeh, D., Amini, S. M., Rahmati, M. M., Golshekan, M., Abedinzade, M., Ahmadi, E., Singh, N. C., & Najafi, M. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266299112240514103048 · Cited by 11
Uppalapati, D., Ohta, N., Zhang, Y., Kawabata, A., Pyle, M. M., Becker, K. G., Troyer, D. L., & Tamura, M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001582 · Cited by 10
Xu, C., Wang, M., Zandieh‐Doulabi, B., Sun, W. Y., Wei, L., & Liu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740783 · Cited by 10
LEE, S.-W., JEON, T. J., & BISWAL, S. (2015) · Oncology Reports · doi:10.3892/or.2015.3711 · Cited by 10
RHYU, J. J., Yun, J.-W., Kwon, E., Che, J., & Kang, B.-C. (2015) · Oncology Reports · doi:10.3892/or.2015.4185 · Cited by 10
Detection of endogenously circulating mesenchymal stem cells in human cancer patients
Velden, D. L. V. D., Houthuijzen, J. M., Roodhart, J. M. L., van Werkhoven, E. D., & Voest, E. E. (2018) · International Journal of Cancer · doi:10.1002/ijc.31727 · Cited by 10
Zurmukhtashvili, M., Machavariani, A., Dugashvili, G., Grdzelidze, T., Gogilashvili, K., Menabde, G., Abiatari, I., & Marks, L. A. M. (2020) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13006 · Cited by 11
The Role of the Myofibroblast in Fibrosis and Cancer Progression
Hinz, B., Darby, I. A., Gabbiani, G., & Desmoulière, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0659-0_3 · Cited by 11
Quaranta, P., Focosi, D., Freer, G., & Pistello, M. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0145 · Cited by 11
Raman spectrum reveals Mesenchymal stem cells inhibiting HL60 cells growth
Su, X., Fang, S., Zhang, D.-S., Zhang, Q., Lü, X., Tian, J., Fan, J., & LiyunZhong (2017) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2017.01.021 · Cited by 10
Potential of Mesenchymal Stem Cells in Anti-Cancer Therapies
Kostadinova, M., & Mourdjeva, M. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200310171547 · Cited by 10
Chen, X., Lin, X., Zhao, J., Shi, W., Zhang, H., Wang, Y., Kan, B., Du, L., Wang, B., Wei, Y., et al. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300409 · Cited by 10
Treating end-stage liver diseases with mesenchymal stem cells: An oak is not felled at one stroke
Li, Z., He, C. H., Xiao, J., & Chen, Z. (2013) · OA Tissue Engineering · doi:10.13172/2052-9643-1-1-583 · Cited by 10
Yang, E., Jing, S., Wang, Y., Wang, H., Rodriguez, R., & Wang, Z. (2023) · Stem Cells International · doi:10.1155/2023/7059289 · Cited by 13
Stem Cell Therapeutics for Cancer
Dwyer, R. M. (2013) · Wiley eBooks · doi:10.1002/9781118660423 · Cited by 9
Gil‐Ortega, M., Fernández‐Alfonso, M. S., Somoza, B., Casteilla, L., & Sengenès, C. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.243 · Cited by 13
Mesenchymal Stromal Cell Dependent Regression of Pulmonary Metastasis from Ewing’s
Hayes-Jordan, A. A., Wang, Y. X., Walker, P., & Cox, C. S. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00044 · Cited by 9
Adelipour, M., Babaei, F., Mirzababaei, M., & Allameh, A. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.01.007 · Cited by 10
An answer to colon cancer treatment by mesenchymal stem cell originated from adipose tissue.
İplik, E. S., Ertuğrul, B., Kozanoğlu, İ., Baran, Y., & Çakmakoğlu, B. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2018.26152.6420 · Cited by 11
Aoki, M., Kakimoto, K., Goto, M., & Higuchi, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-53807-w · Cited by 9
RetractedExtracellular Vesicles in Cancer Progression: Are They Part of The Problem or Part of The Solution?
Scholl, J. N., Dias, C. K., Müller, L., Battastini, A. M. O., & Figueiró, F. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0256 · Cited by 12
Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold Nanoparticles
Pullambhatla, M., Rowe, S. P., Lisok, A., Wang, Y., Todd, G. P., Danilkovitch, A., & Pomper, M. G. (2020) · Tomography · doi:10.18383/j.tom.2020.00026 · Cited by 10
Local drug delivery system for the treatment of tongue squamous cell carcinoma in rats
Kakabadze, M., Paresishvili, T., Mardaleishvili, K., Vadachkoria, Z., Kipshidze, N. N., Jangavadze, M., Karalashvili, L., Ghambashidze, K., Chakhunashvili, D., & Kakabadze, Z. (2021) · Oncology Letters · doi:10.3892/ol.2021.13131 · Cited by 12
Kim, Y.-S., Hwang, K., Go, R., Kim, C., & Choi, K. (2015) · Oncology Reports · doi:10.3892/or.2015.3846 · Cited by 9
Hu, J., Zhou, Z., Shi, S., Zhu, X., Wang, X.-H., Zhang, W., HU, S., Qian, H., & Xu, W. (2012) · Oncology Letters · doi:10.3892/ol.2012.1003 · Cited by 10
Taraballi, F., Pastò, A., Bauza, G., Varner, C., Amadori, A., & Tasciotti, E. (2019) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2019.100017 · Cited by 12
Jingjing, H., Hongna, H., Wen-fu, Z., Jianlin, L., Huang, G., Yuanjia, L., Songlin, C., & Hu, Y. (2021) · International Journal of Stem Cells · doi:10.15283/ijsc20157 · Cited by 10
Zhang, T., Lee, W., Rui, Y., Cheng, T. Y., & Li, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt047.9 · Cited by 8
Regmi, S., & Jeong, J. (2016) · Macromolecular Research · doi:10.1007/s13233-016-4107-4 · Cited by 8
Effect of Bone-Marrow-Derived Mesenchymal Stem Cells on the Healing of Bone Fractures
Mohammed, S. A., Elsattar, M. A., Abd-Allah, S. H., Habashy, O. Y., Abdelghany, E. M. A., Hussein, S., & Abdullah, O. (2021) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2021.0093 · Cited by 9
The Role of Mesenchymal Stem Cells in the Tumor Microenvironment
Aline, M., & Ruth, S. (2012) · InTech eBooks · doi:10.5772/31933 · Cited by 7
Burns, J. S., Safwat, A., Grisendi, G., Kassem, M. S., & Dominici, M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.027 · Cited by 8
BenCheng, S., Wang, X., Pan, Y., Jiao, Y., Qi, Y., Gong, H., & Jiang, D. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s203910 · Cited by 7
Mesenchymal Stem Cells in Cancer: a New Link to Neutrophils
(2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.288 · Cited by 7
Tang, K., Hu, L., Ma, J., Zhang, H., Zhang, Y., Li, Y., Ma, R., Luo, S., Liu, D., Long, G., et al. (2015) · Stem Cells · doi:10.1002/stem.2076 · Cited by 8
Wharton’s Jelly Stromal Cells as Potential Delivery Vehicles for Cancer Therapeutics
Rachakatla, R. S., & Troyer, D. L. (2009) · Future Oncology · doi:10.2217/fon.09.99 · Cited by 9
Stem Cell-Dependent Therapies: Mesenchymal Stem Cells in Chronic Inflammatory Disorders
Gross, G., & Häupl, T. (2013) · De Gruyter eBooks · doi:10.1515/9783110298307 · Cited by 9
Svitina, H. M., Kyryk, V. M., Skrypkina, I., Кучма, М. Д., Bukreieva, T., Areshkov, P. O., Shablii, I., Denis, Y., Klymenko, P. P., Garmanchuk, L., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4792 · Cited by 7
Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
Lovato, L., de Rosbo, N. K., & Uccelli, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7953-6_20 · Cited by 7
Mu, L., Sui, W., Yang, L., Yu, W., Su, H., Yu, X., & Qin, C. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.06.04 · Cited by 7
Stem Cell‐Mediated Prodrug Gene Therapy of High‐Grade Brain Tumors
Altaner, Č. (2013) · Wiley eBooks · doi:10.1002/9781118660423.ch5 · Cited by 7
Murillo, L. L., Sugden, C. J., Ózsvári, B., Moftakhar, Z., Hassan, G. S., Sotgia, F., & Lisanti, M. P. (2024) · Cells · doi:10.3390/cells13242059 · Cited by 7
Kan, H., jinzhao, H., Gui, X., Tian, W., Fan, L.-J., Chen, X., Ding, X., Chen, L., & Shen, W. (2025) · The Korean journal of pain · doi:10.3344/kjp.24374 · Cited by 6
NKG2D-CAR-targeted iPSC-derived MSCs efficiently target solid tumors expressing NKG2D ligand
Tang, S., Zhang, Y., Wang, P., Tang, Q., Liu, Y., Lu, F., Han, M., Zhou, M., Hu, Q. N., Feng, M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112343 · Cited by 7
Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment
Kangari, P., Salahlou, R., & Vandghanooni, S. (2024) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2024.052 · Cited by 7
Luo, D., Yan, X., Liu, D., Zhou, X., & Liu, G. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1600-3 · Cited by 6
Mesenchymal stem cells inhibit the growth of prostate carcinoma cells in a long-term cultivation
Kostadinova, M., Antonov, B., Kinov, P. S., Oreshkova, T., & Mourdjeva, M. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1751710 · Cited by 6
Solovyeva, V. V., Kitaeva, K. V., Chulpanova, D. S., Arkhipova, S. S., Filin, I. Y., & Rizvanov, A. A. (2022) · BioNanoScience · doi:10.1007/s12668-021-00931-5 · Cited by 6
Opo, F. A. D. M., Moulay, M., Alrefaei, G. I., Alsubhi, N. H., Alkarim, S., & Rahman, M. M. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.103519 · Cited by 6
EMT and Tumor Turning Point Analysis in 3D Spheroid Culture of HNSCC and Mesenchymal Stem Cells
Brylka, S., & Böhrnsen, F. (2022) · Biomedicines · doi:10.3390/biomedicines10123283 · Cited by 7
Production of Clinical Grade Mesenchymal Stromal Cells
Pytlik, Slanar, Stehlik, & Matejkov (2011) · InTech eBooks · doi:10.5772/22428 · Cited by 6
Mesenchymal Stem Cells: How Can we Realize their Therapeutic Potential in Cancer Therapy?
Baird, S. K. (2015) · Journal of Clinical & Experimental Pathology · doi:10.4172/2161-0681.1000206 · Cited by 10
Azizi, P., Mazhari, S., Tokhanbigli, S., Noukabadi, F. N., Abkenar, E. D., Shamsafzali, E., & Baghaei, K. (2019) · Gastroenterology and hepatology from bed to bench. · Cited by 6
Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy
Gharbavi, M., Sharafi, A., & Ghanbarzadeh, S. (2020) · Current Gene Therapy · doi:10.2174/1566523220666200607190339 · Cited by 6
Hasgur, S., Desbourdes, L. M., Relation, T., Overholt, K. M., Stanek, J. R., Guess, A. J., Yu, M., Patel, P. A., Roback, L., Dominici, M., et al. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2020.04.102 · Cited by 6
Therapeutic Purposes and Risks of Ex Vivo Expanded Mesenchymal Stem/Stromal Cells
Bouchlaka, M. N., Hematti, P., & Capitini, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803102-5.00022-7 · Cited by 7
Sun, M., Zhu, H., Yang, Y. P., Yao, Y., Li, H., Feng, F., Wáng, Q., Liu, R., & Sun, C. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5742 · Cited by 9
Vahdanikia, V., Maleki, M., Iranifam, R. A., & Abdi, A. (2022) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v16i2.9204 · Cited by 5
Oraee‐Yazdani, S., Akhlaghpasand, M., Rostami, F., Golmohammadi, M., Tavanaei, R., Shokri, G., Hafizi, M., Oraee-Yazdani, M., Zali, A., & Soleimani, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1060180 · Cited by 6
Liu, W., Hao, M., Xu, Y., Ren, X., Hu, J., Wang, L., Chen, X., & Lv, Q. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03831-0 · Cited by 6
Nakagaki, S., Arimura, Y., Nagaishi, K., Isshiki, H., Nasuno, M., Watanabe, S., Idogawa, M., Yamashita, K., Naishiro, Y., Adachi, Y., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1049-0 · Cited by 5
Genetically Engineered Mesenchymal Stem Cells
Shah, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416606-6.00001-5 · Cited by 5
Effect of Extracellular Vesicles Derived From Mesenchymal Stem Cells on K-562 Leukemia Cell Line
Valandani, H. M., Amirizadeh, N., Nikougoftar, M., Safa, M., Khalilabadi, R. M., & Kazemi, A. (2018) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.64991 · Cited by 7
Mesenchymal stem cell exosomes: a promising delivery system for glioma therapy
Ma, T., Su, G., Wu, Q., Shen, M., Feng, X., & Zhang, Z. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2023-0482 · Cited by 5
Adipose Tissue-Derived Stem Cells in Regenerative Medicine and Impact on Cancer
Thiagarajan, P. S., & Reizes, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803892-5.00016-4 · Cited by 7
The Duality of Stem Cells: Double-Edged Sword in tumor Evolution and Treatment
Tajnšek, U., Motaln, H., Levičar, N., Rotter, A., & Lah, T. T. (2013) · Springer eBooks · doi:10.1007/978-94-007-6211-4_15 · Cited by 5
Cytotherapies in multiple myeloma: a complementary approach to current treatments?
Ciavarella, S., Caselli, A., Savonarola, A., Tamma, A. V., Tucci, M., & Silvestris, F. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.796357 · Cited by 5
ENCAPSULATION OF MESENCHYMAL STROMAL CELLS IN ALGINATE MICROSPHERES
Tarusin, D. N. (2016) · Biotechnologia Acta · doi:10.15407/biotech9.04.058 · Cited by 6
Folcuti, R. M., Siloşi, I., Purcaru, Ş. O., Tache, D. E., Georgescu, A. M., Emami, G., & Dricu, A. (2015) · PubMed Central · doi:10.12865/chsj.41.04.08 · Cited by 5
Chistyakova, I. A., & Poljanskaya, G. G. (2015) · Cell and Tissue Biology · doi:10.1134/s1990519x15020042 · Cited by 5
Ghaedamini, S., Kazemi, M., Rabiei, A., Honarvar, A., Aliakbari, M., & Karbasi, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106315 · Cited by 4
Rahmatizadeh, F., Pashaei-Asl, F., Dehcheshmeh, M. M., Rahbar, S., LaleAtaei, M., Aziz, S. G., Rad, J. S., & Pashaiasl, M. (2019) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2020.51 · Cited by 4
Jayaraman, H., Anandhapadman, A., & Ghone, N. V. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04119-9 · Cited by 4
Stepanov, Y. V., Golovynska, I., Ostrovska, G. V., Pylyp, L. Y., Dovbynchuk, T., Stepanova, L. I., Gorbach, O. I., Shablii, V., Xu, H., Garmanchuk, L., et al. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24814 · Cited by 4
Human Mesenchymal Stem Cells Migrate toward Colon Cancer Partially Regulated by HMGB1
ホシノ, ゴ. (2013) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000145 · Cited by 4
Kandarakov, O. F., Kopantseva, E., & Belyavsky, A. V. (2016) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-016-3561-5 · Cited by 4
Hardiany, N. S., Yo, E. C., Ngadiono, E., & Wanandi, S. I. (2019) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2019.26.6.4 · Cited by 4
Wilhelm, C., Scherzad, A., Bregenzer, M., Meyer, T. J., Gehrke, T. E., Kleinsasser, N. H., Hagen, R., & Hackenberg, S. (2020) · Oncology Letters · doi:10.3892/ol.2020.12092 · Cited by 4
Mesenchymal Stem Cell Therapy: Immunomodulation and Homing Mechanisms
Yagi, H., Soto–Gutiérrez, A., Kitagawa, Y., & Yarmush, M. L. (2012) · Stem cells and cancer stem cells · doi:10.1007/978-94-007-4798-2_9 · Cited by 4
Metadata
- Authors
- Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., Zhang, J., Raffeld, M., Rogers, T. B., Stetler-Stevenson, W., Frank, J. A., Reitz, M., & Finkel, T.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Maryland Biotechnology Institute (US)
- National Institutes of Health (US)
- Flow Cytometry Core Facility (CH)
- 1Laboratory of Molecular Biology, Cardiovascular Branch,
- National Heart, Lung, and Blood Institute (US)
- University of Maryland, Baltimore (US)
- National Cancer Institute (UA)
- 4National Cancer Institute; and
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1235-1247
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2121206
- OpenAlex
- W2163234891
- Cited by
- 747
- References
- 60
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 20 · 2023: 31 · 2022: 25 · 2021: 34 · 2020: 37 · 2019: 41 · 2018: 38 · 2017: 28 · 2016: 53 · 2015: 56 · 2014: 38 · 2013: 79 · 2012: 51
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Cancer Institute (1R01 CA09905-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- mesenchymal stem cells, Kaposi's sarcoma, anticancer activity, Akt signaling, E-cadherin, cell-cell contact, tumor stroma, stem cell homing, tumor suppression, stem cell therapy
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Sarcoma, Kaposi, Transplantation, Heterologous, Tumor Cells, Cultured, Stromal Cells, Graft vs Tumor Effect, Mesenchymal Stem Cell Transplantation, Oncogene Protein v-akt, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.